Literature DB >> 32926602

Pharmacotherapy for Treatment-Resistant Obsessive-Compulsive Disorder.

Reilly R Kayser1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32926602      PMCID： PMC7495343          DOI： 10.4088/JCP.19ac13182

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  24 in total

Review 1.  Practice guideline for the treatment of patients with obsessive-compulsive disorder.

Authors:  Lorrin M Koran; Gregory L Hanna; Eric Hollander; Gerald Nestadt; Helen Blair Simpson
Journal:  Am J Psychiatry       Date:  2007-07       Impact factor: 18.112

Review 2.  Obsessive-compulsive disorder (OCD): Practical strategies for pharmacological and somatic treatment in adults.

Authors:  Naomi A Fineberg; Samar Reghunandanan; Helen B Simpson; Katharine A Phillips; Margaret A Richter; Keith Matthews; Dan J Stein; Jitender Sareen; Angus Brown; Debbie Sookman
Journal:  Psychiatry Res       Date:  2015-02-11       Impact factor: 3.222

3.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

Review 4.  Current and up-and-coming pharmacotherapy for obsessive-compulsive disorder in adults.

Authors:  Giacomo Grassi; Stefano Pallanti
Journal:  Expert Opin Pharmacother       Date:  2018-10-15       Impact factor: 3.889

5.  Intranasal Ketamine and Cognitive-Behavioral Therapy for Treatment-Refractory Obsessive-Compulsive Disorder.

Authors:  Thomas G Adams; Michael H Bloch; Christopher Pittenger
Journal:  J Clin Psychopharmacol       Date:  2017-04       Impact factor: 3.153

Review 6.  A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.

Authors:  M H Bloch; A Landeros-Weisenberger; B Kelmendi; V Coric; M B Bracken; J F Leckman
Journal:  Mol Psychiatry       Date:  2006-04-04       Impact factor: 15.992

7.  Combination Therapy of Serotonin Reuptake Inhibitors and Memantine for Obsessive- Compulsive Disorder: A Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials.

Authors:  Taro Kishi; Yuki Matsuda; Nakao Iwata
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

8.  Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder.

Authors:  M H Bloch; J McGuire; A Landeros-Weisenberger; J F Leckman; C Pittenger
Journal:  Mol Psychiatry       Date:  2009-05-26       Impact factor: 15.992

Review 9.  Transcranial magnetic stimulation in the treatment of obsessive-compulsive disorder: current perspectives.

Authors:  Ana Lusicic; Koen Rj Schruers; Stefano Pallanti; David J Castle
Journal:  Neuropsychiatr Dis Treat       Date:  2018-06-29       Impact factor: 2.570

Review 10.  Glutamatergic augmentation strategies in obsessive-compulsive disorder.

Authors:  Karthik Sheshachala; Janardhanan C Narayanaswamy
Journal:  Indian J Psychiatry       Date:  2019-01       Impact factor: 1.759
View more
  1 in total

Review 1.  Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain.

Authors:  Elaine Meade; Sarah Hehir; Neil Rowan; Mary Garvey
Journal:  J Fungi (Basel)       Date:  2022-03-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.